Objective: To evaluate the safety and effectiveness of antibiotics in reducing the infectious complications following closed tube thoracostomy for isolated chest trauma. Design: Double-blind, randomized clinical trial. Setting: Medical school affiliated large urban teaching hospital and trauma center. Patients: One hundred nineteen of 159 patients over 18 years old presenting to the emergency department requiring closed tube thoracostomy for isolated chest injuries (113 penetrating, 6 blunt). Intervention: Patients received either placebo or 1 g cefonicid daily intravenously started at chest tube insertion and stopped within 24 h of removal. Measurements and results: The development of wound infections, pneumonia (CDC criteria), or empyema; the incidence of adverse events; length of hospitalization. One nonspecific infection was seen in the cefonicid group (1.6 percent) and six respiratory tract infections Individuals frequently present to the emergency department following thoracic trauma with the common complications of these injuries being pneumothorax and hemothorax. The treatment of these isolated injuries not requiring open surgical intervention is with closed tube thoracostomy. While the use of antibiotics has been well established for many operative procedures,' the routine administration of systemic antibiotics for chest tube placement remains debatable, although it is believed that between 2 to 25 percent of these patients would be expected to develop infectious complications related to their wounds or treatment. 2 The most common infectious complications in these patients are of the respiratory tract, specifically empyema and pneumonia. Those patients with other injuries requiring additional surgical intervention most often are given antibiotic therapy. It is specifically those with isolated chest wounds due to penetrating or blunt trauma not requiring surgery in which the use of antibiotics is debated. Contaminating bacteria may be introduced into the pleural space through damaged bronchial passages or from external contamination by way of the penetrating object or chest tube itself. Other variables related to infections include delayed or inadequate tube placement. When administered, the antibiotic should have activity against those organisms most likely to cause infections, ie, Gram-positive bacteria.
Previous prospective clinical studies have not shown a definitive advantage of antibiotics in lowering the incidence of infectious complications.3-8 A recent article has attempted to statistically combine six studies of isolated chest trauma requiring thoracostomy using the technique of meta-analysis and indicated that antibiotics, in general, have the desirous effect of lowering infections.9
The primary purpose of this study was to prospectively evaluate the effectiveness of a limited number CHEST / 106 / 5 / NOVEMBER, 1994 1493 of doses of a long-acting parenteral antibiotic (1 g daily) in the prevention of infectious complications in patients with isolated chest injury requiring closed tube thoracostomy without additional surgical procedures. The secondary aims were to evaluate the incidence of adverse events and possible changes in duration of hospitalization, peak temperature, and peak WBC counts.
MATERIALS AND METHODS
Male and female adult patients who presented to the Emergency Department of Charity Hospital, Medical Center of Louisiana at New Orleans, between January 1988 and April 1992, with isolated traumatic or blunt chest injuries requiring closed tube thoracostomy were eligible for inclusion in the study. Patients were excluded for pregnancy, age younger than 18 years old, impaired renal function as shown by creatinine concentration >-2.0 mg/dl, allergy to cephalosporin antibiotics, or the administration of antibiotics within 3 days prior to injury. Additional exclusions were the presence of underlying conditions, eg, infection, or other disease states that would interfere with evaluation of antibiotic effect. Patients with injuries requirirng additional antibiotic therapy or surgical intervention were excluded. Prior to randomization, all patients signed a written informed consent approved by the Tulane Medical Center Institutional Review Board. They were then interviewed and a pertinent physical examination was performed to evaluate the extent of injuries and any underlying conditions. A negative urine pregnancy test result was required of all female subjects of childbearing potential. Samples for bacteriologic culture were obtained pretreatment from the traumatic wound and as required from appropriate sites afterwards. Hematology, serum chemistry, and urinalysis testing were performed before, during, and after treatment. Patients were randomly assigned by computer-generated schedule in a double-blind manner to receive either 1 g of cefonicid or a placebo solution of 5 percent dextrose in water intravenously once per 24 h. Drug administration was started as soon as possible, continued for the duration of the chest tube placement, and was stopped within 24 h following removal. Daily patient assessment included chest radiography, pertinent physical examination for signs of infection, and vital sign monitoring.
Chest tube placement was performed in the emergency department by the treating physician using sterile gloves and mask. The insertion site was prepared using a povidone-iodine scrub. Tube placement was then verified by radiography.
Treatment failure was defined as a wound infection requiring surgical intervention or additional antibiotic therapy, empyema requiring drainage, pneumonia using criteria as defined by the Center for Disease Control and Prevention (CDC),10 or other presumed systemic infection as indicated by the patient's signs and symptoms. Pneumonia was defined as either (1) rales or dullness to percussion on physical examination plus one of the following-(a) purulent sputum, (b) pathogen isolated from blood culture, or (c) pathogen isolated from transtracheal aspirate, bronchial brushing, or biopsy specimen or (2) radiographic examination showing new or progressive infiltrate, consolidation, or pleural effusion plus one of the above criteria (a through c) or (d) histopathologic evidence of pneumonia. Other lower respiratory tract infections required one of the following: (1) organisms seen on smear or isolated from culture of lung tissue or fluid, (2) lung abscess or empyema seen during surgery or by histopathologic examination, or (3) abscess cavity seen on radiographic examination. Patients failing treatment were placed on regimens of other antibiotics as needed. All patients were followed up for the duration of their clinic visits, up to 30 days.
The sample size of 60 patients per group was determined using standardized one-tailed formulas for hypothesis testing of two population proportions." An untreated infection rate of 20 percent and a proposed treated rate of 5 percent with a=0.05 and 3=0.8 were used. All statistical testing was done using one method (Statview 4.01, Abacus Concepts, Berkeley, Calif). Days of chest tube, days of therapy, peak WBC counts, length of hospitalization, and peak temperatures were compared by unpaired t tests (twotailed). The Mann-Whitney rank sum test (nonparametric) was also used to compare the above variables if the distributions varied from normal. Infection rates were compared by contingency table analysis (X2 and Fisher's exact test). All tests were done with a=O.05. Patients were excluded from the primary statistical analysis if it was determined that they did not qualify for protocol inclusion, eg, surgical intervention was required for proper medical treatment. Patients excluded for errors in medication were followed-up for the development of infectious complications and for days of chest tube use, therapy, and hospitalization (intent-to-treat analysis).
RESULTS
A total of 159 patients presumptively fulfilled the criteria for study inclusion and were randomized to one of the two treatment arms. Subsequently, 40 were deemed not to be evaluable, either for death due to the original trauma, errors in antibiotic administration (insufficient protocol therapy or additional antibiotics administered), not fulfilling entry criteria, unavailability for follow-up, or for the performance of necessary surgical procedures (Table 1 ). There were two early deaths among the study population and two were entered into the protocol in error. The relatively large number of patients removed for undergoing surgical procedures (7 antibiotic; 14 placebo) resulted from the patients being placed in the protocol early in their treatment and subsequently deemed to require an operative procedure for appropriate medical care. Two patients left the hospital before completion of their therapy and were unavailable for follow-up. Thirteen patients (9 antibiotic; 4 placebo) received either insufficient doses to judge the effects of therapy or were given additional antibiotics in error. Of the qualified patients, 63 (53 percent) received antibiotic treatment and 56 (47 percent) received placebo. The two study groups were comparable in demographics with male subjects being the most common (Table 2 ). Most wounds (103) teria recovered from the patients' infections (Table 4) were generally the normal respiratory and skin organisms with the exception of one recovery of a Clostridium. The failures in the placebo group required additional closed drainage of the empyema with one patient also requiring thoracotomy and decortication. All seven failures were treated with appropriate additional therapy, including antibiotics, and were subsequently cured. An intent-to-treat analysis was performed to include those patients who had been excluded from the primary analyses due to medication errors. No differences from the results reported above were found for days of therapy, chest tube usage, or length of hospitalization. As no additional infections developed among the excluded patients, the statistical significance of antibiotic usage vs placebo was slightly increased (p=0.0279, x2; p=0.0464, Fisher's exact test).
DISCUSSION
The treatment of a patient arriving in the emergency department with isolated blunt or penetrating traumatic chest injury resulting in pneumothorax or hemothorax routinely includes the placement of intercostal thoracostomy tube drainage for rapid pulmonary expansion and evacuation of the pleural cavity. There has been considerable variation and debate over the need for or use of systemic antibiotics in these patients with no clear-cut proof of its effectiveness.1 The purpose of the antibiotic is the prevention of an infection resulting from bacterial contamination occurring either at the time of the initial trauma or during the therapeutic tube thoracostomy. It has been also hypothesized that the tube thoracostomy itself might contribute to infections by providing a route for bacterial contamination.12 The rate of infections after tube thoracostomy reported in the literature varies widely, from 2 to 25 percent.2
There have been several clinical studies debating the effectiveness of antibiotics in this patient population having isolated chest trauma requiring chest tubes. Many of the earlier studies were retrospective in design, while six of the more recent articles were prospective randomized trials of appropriate antibiotics started early in the clinical course (Table 5) . [3] [4] [5] [6] [7] [8] However, only two protocols were of blinded design.3'4 The other articles cited5-8 were not blinded, introducing the question of bias because the treating physicians may have been more likely to start antibiotic therapy if they knew the patient was receiving placebo but might wait if the patient was already receiving an active drug. While different antibiotics were used in each study, all had activity against the bacteria normally expected to cause infections in the population studied. Antibiotic treatment was found to significantly reduce empyema in only two of the studies7'8 and to significantly reduce any infectious complication in four of the studies.3'4'7'8 Because of the inconsistency of the results, any advantage of antibiotic usage remains in doubt. All the studies cited suffered from small group sizes and most likely a high A error. In an attempt to analyze the previous studies, Fallon and Wears9 performed a meta-analysis of the six studies. This technique statistically synthesizes results from separate but similar studies by grouping them together. They concluded from their analysis that antibiotics might be of value in those patients who are at risk for empyema.
Several of the previous protocols suffered from poor definitions of what distinguishes an infection.
They often used only radiographic evidence of pneumonia or the so-called "febrile morbidity." Although the presence of only increased temperatures or WBC counts may or may not be of clinical significance, we chose to include these data since most previous work has addressed these criteria. When we limited the analysis to include only the important respiratory tract infections, (using the current CDC Antibiotic Use in Thoracic Injuries Requiring Closed Tube Thoracostomy (Nichols et al) criteria for pneumonia, we were able to demonstrate a statistically important difference between the two groups with an almost 11 percent incidence of infection when antibiotics were not administered. Even if we add in the one antibiotic-treated patient with a nonspecific septic course, the difference between placebo and antibiotic remains significant. Although it has been suggested that just being in an intensive care unit increases the incidence of infections, we did not observe any correlation in our patients. The bacteria recovered from the infected patients were either normal respiratory tract or skin microflora with the exception of the single isolation of Clostridium bifermentans. This organism has been recovered from both intestinal contents and from soil. As no additional nonthoracic injuries were identified in this patient, we have to assume that the organism most likely was from an exogenous source.
In the present study, both antibiotic and placebo groups received approximately 5 days of treatment that was directly related to the length of the thoracostomy tube employment. Previous studies indicated that placebo-treated patients required the chest tube for longer periods than the antibiotic-treated patients.6-8 One study reported that patients treated with cephapirin required that thoracostomy tubes be kept in for more than 2 days longer than the placebo-treated patients.5 We believe that the length of chest tube usage is primarily related to the severity of the initial injury rather than the antibiotic treatment. Although not statistically significant, the average length of hospitalization in our patients tended to be less with the use of antibiotics (Table 3) . This was also shown by Grover et al, 3 Stone et al,4 and Mandal and colleagues,6 while the study reported by LeBlanc and Tucker5 showed that the patients treated with cephapirin stayed in the hospital approximately 3 days longer. The total length of hospitalization is related to many variables, including the incidence of infectious complications.
It can be seen in Table 5 that the average number of antibiotic doses administered in the prospective trials of antibiotic usage for isolated chest trauma requiring tube thoracostomy was quite variable, ranging from 5 in the present study to 30 reported by LeBlanc and Tucker.5 As noted above, several of the studies demonstrated shorter lengths of hospitalization with the use of antibiotic treatment. Our data indicate that 1 g of cefonicid daily was likewise effective in reducing the length of hospitalization. This drug has an average wholesale cost of $26.10 per gram vial.13 Daily hospital costs in the United States now average between $688 in government-run institutions to $820 in private for-profit facilities. '4 In the present study, the antibiotic-treated patients averaged 0.9 days less hospitalization and received an average of five doses of cefonicid for a potential saving of between $488 and $607 per patient (excluding costs of administration). The potential cost savings become most evident when all patients with infections are compared with those without infections. Here there was a difference of over 8 days in average duration of hospitalization. This translates to a potential additional hospitalization cost of $3,900 to $4,800 per infection.
There is currently a movement to administer a 12 to 24 h of antibiotics have been suggested to be effective in patients in whom there is colonic contamination, it appears logical that a limited antibiotic administration should be tested in reducing infections following chest tube placement. As contrasted with the previous trials in which antibiotics were administered throughout the duration of chest tube usage, future studies might utilize a broad-spectrum cephalosporin with a long half-life for 1 day or perhaps even a single dose at the time of tube insertion. It is imperative that the antibiotic used be effective against the usual respiratory pathogens. Our results strongly show the value of a limiteddose regimen of cefonicid in the prevention of empyema and pneumonia following tube thoracostomy for isolated chest trauma. The patients receiving antibiotics had fewer infections and a clinically important reduced average duration of hospitalization. As there were no important side effects seen in those receiving the cefonicid, it appears that the routine administration of antibiotics is both cost-effective and beneficial in the prevention of infections following tube thoracostomy for isolated chest trauma.
